Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Nutr Biochem ; 35: 48-57, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27376728

RESUMO

Altered intestinal microbiota and subsequent endotoxemia play pathogenic roles in diabetes. We aimed to study the mechanisms of intestinal defense impairment in type 1 diabetes and the effects of Lactobacillus salivarius as well as fructooligosaccharides (FOS) supplementation on diabetes-induced bacterial translocation. Alterations in the enteric microbiome, expression of mucosal antibacterial proteins and bacteria-killing activity of the intestinal mucosa in streptozotocin (STZ)-induced diabetic mice and Ins2(Akita) mice were investigated. The effects of dead L. salivarius (2×10(8)CFU/ml) and FOS (250 mg per day) supplementation for 1 week on endotoxin levels and Klebsiella pneumoniae translocation were also examined. Finally, germ-free mice were cohoused with wild-type or Ins2(Akita) mice for 2 weeks to examine the contribution of microbiota on the antibacterial protein expression. STZ-induced diabetic mice developed intestinal defense impairment as demonstrated by decreased mucosal bacteria-killing activity; reduction of non-defensin family proteins, such as Reg3ß, Reg3γ, CRP-ductin and RELMß, but not the defensin family proteins; and increased bacterial translocation. Intestinal bacteria overgrowth, enteric dysbiosis and increased intestinal bacterial translocation, particularly pathogenic K. pneumoniae in STZ-induced diabetic mice and Ins2(Akita) mice, were noted. Treating diabetic mice with dead L. salivarius or FOS reversed enteric dysbiosis, restored mucosal antibacterial protein and lessened endotoxin levels as well as K. pneumoniae translocation. Moreover, germ-free mice cohoused with wild-type mice demonstrated more intestinal Reg3ß and RELMß expression than those cohoused with Ins2(Akita) mice. These results indicate that hyperglycemia induces enteric dysbiosis, reduction of non-defensin proteins as well as bacteria-killing activity of the intestinal mucosa and intestinal defense impairment. Reversal of enteric dysbiosis with dead L. salivarius or FOS supplementation decreases diabetes-induced K. pneumoniae translocation and endotoxin levels through the induction of non-defensin proteins.


Assuntos
Diabetes Mellitus Tipo 1/dietoterapia , Suplementos Nutricionais , Disbiose/dietoterapia , Imunidade nas Mucosas , Mucosa Intestinal/microbiologia , Ligilactobacillus salivarius/imunologia , Animais , Translocação Bacteriana , Diabetes Mellitus Tipo 1/imunologia , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/microbiologia , Disbiose/imunologia , Disbiose/metabolismo , Disbiose/microbiologia , Endotoxinas/antagonistas & inibidores , Endotoxinas/sangue , Endotoxinas/metabolismo , Regulação da Expressão Gênica , Vida Livre de Germes , Hormônios Ectópicos/agonistas , Hormônios Ectópicos/genética , Hormônios Ectópicos/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular , Mucosa Intestinal/imunologia , Mucosa Intestinal/metabolismo , Klebsiella pneumoniae/imunologia , Klebsiella pneumoniae/metabolismo , Klebsiella pneumoniae/fisiologia , Ligilactobacillus salivarius/química , Masculino , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Oligossacarídeos/uso terapêutico , Proteínas Associadas a Pancreatite , Prebióticos , Proteínas/agonistas , Proteínas/genética , Proteínas/metabolismo , Distribuição Aleatória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...